第一单位：
Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.;Claude Bernard Lyon 1 University, Lyon, France.
作者：
Pierre,Sesques [1]
;
Emmanuelle,Ferrant [2]
;
Violaine,Safar [2]
;
Florent,Wallet [3]
;
Jérémie,Tordo [4]
;
Anthony,Dhomps [4]
;
Lionel,Karlin [2]
;
Gabriel,Brisou [1]
;
Marlène,Vercasson [2]
;
Carole,Hospital-Gustem [2]
;
Vérane,Schwiertz [5]
;
Florence,Ranchon [6]
;
Catherine,Rioufol [6]
;
Marion,Choquet [2]
;
Pierre,Sujobert [7]
;
Dana,Ghergus [2]
;
Fadhela,Bouafia [2]
;
Camille,Golfier [1]
;
Helène,Lequeu [2]
;
Anne,Lazareth [2]
;
Silvana,Novelli [8]
;
Perrine,Devic [9]
;
Alexandra,Traverse Glehen [10]
;
Sébastien,Viel [11]
;
Fabienne,Venet [12]
;
Valérie,Mialou [13]
;
Olivier,Hequet [13]
;
Adrien,Chauchet [14]
;
Yazid,Arkam [15]
;
Emmanuelle,Nicolas-Virelizier [16]
;
Frederic,Peyrade [17]
;
Doriane,Cavalieri [18]
;
Florence,Ader [19]
;
Hervé,Ghesquières [20]
;
Gilles,Salles [20]
;
Emmanuel,Bachy [20]
作者单位：
Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.;Claude Bernard Lyon 1 University, Lyon, France.
[1]
Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.
[2]
Department of Critical Care, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.
[3]
Department of Nuclear Medicine, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.
[4]
Department of Pharmacy, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.
[5]
Claude Bernard Lyon 1 University, Lyon, France.;Department of Pharmacy, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.
[6]
Claude Bernard Lyon 1 University, Lyon, France.;Department of Hematology Laboratory, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.;Lyon Cancer Research Center, INSERM U1052 and CNRS UMR5286, Lyon, France.
[7]
Lyon Cancer Research Center, INSERM U1052 and CNRS UMR5286, Lyon, France.
[8]
Department of Neurology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.
[9]
Claude Bernard Lyon 1 University, Lyon, France.;Lyon Cancer Research Center, INSERM U1052 and CNRS UMR5286, Lyon, France.;Department of Pathology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.
[10]
Claude Bernard Lyon 1 University, Lyon, France.;Department of Biological Immunology, Hospices Civils de Lyon, Lyon Sud Hospital, Lyon, France.;International Center for Research in Infectious Diseases, INSERM U1111 and CNRS UMR5308, Lyon, France.
[11]
Claude Bernard Lyon 1 University, Lyon, France.;Department of Clinical Immunology, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France.
[12]
Department of Biology and Therapy, Etablissement Français du Sang Auvergne-Rhône-Alpes, Decines-Charpieu, France.
[13]
Department of Hematology, Besançon University Hospital, Besançon, France.
[14]
Department of Hematology, Hopital Emile Muller, Mulhouse, France.
[15]
Department of Hematology, Centre Léon Bérard, Lyon, France.
[16]
Department of Hematology, Centre Antoine Lacassagne, Nice, France.
[17]
Department of Hematology, Clermont Ferrand University Hospital, Clermont Ferrand, France.
[18]
Department of Infectious Disease, Hospices Civils de Lyon, Croix Rousse Hospital, Lyon, France.
[19]
Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.;Claude Bernard Lyon 1 University, Lyon, France.;Lyon Cancer Research Center, INSERM U1052 and CNRS UMR5286, Lyon, France.
[20]
医学主题词
成年人(Adult);老年人(Aged);抗原, CD19(Antigens, CD19);抗原, 肿瘤(Antigens, Neoplasm);无病生存(Disease-Free Survival);女(雌)性(Female);法国(France);人类(Humans);免疫疗法, 过继(Immunotherapy, Adoptive);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);男(雄)性(Male);中年人(Middle Aged);回顾性研究(Retrospective Studies);存活率(Survival Rate)
DOI
10.1002/ajh.25951
PMID
32744738
发布时间
2020-12-29
换一批
